PeptideDB

2,6-Dihydroxy-4-methoxyacetophenone 7507-89-3

2,6-Dihydroxy-4-methoxyacetophenone 7507-89-3

CAS No.: 7507-89-3

2,6-Dihydroxy-4-methoxyacetophenone is a phytoalexin that can be extracted from the root tissue of Sanguisorba minor. 2,
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

2,6-Dihydroxy-4-methoxyacetophenone is a phytoalexin that can be extracted from the root tissue of Sanguisorba minor. 2,6-Dihydroxy-4-methoxyacetophenone has antifungal activity. 2,6-Dihydroxy-4-methoxyacetophenone is a strong germination inhibitor of B. cinerea.

Physicochemical Properties


Molecular Formula C9H10O4
Molecular Weight C9H10O4
Exact Mass 182.058
CAS # 7507-89-3
PubChem CID 24135
Appearance Typically exists as solid at room temperature
Density 1.284 g/cm3
Boiling Point 356.7ºC at 760 mmHg
Melting Point 144ºC
Flash Point 146.3ºC
LogP 1.309
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 2
Heavy Atom Count 13
Complexity 180
Defined Atom Stereocenter Count 0
SMILES

CC(C1=C(O)C=C(OC)C=C1O)=O

InChi Key GKSGTWUNURZTKD-UHFFFAOYSA-N
InChi Code

InChI=1S/C9H10O4/c1-5(10)9-7(11)3-6(13-2)4-8(9)12/h3-4,11-12H,1-2H3
Chemical Name

1-(2,6-dihydroxy-4-methoxyphenyl)ethanone
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro 2,6-Dihydroxy-4-methoxyacetophenone possesses antifungal activity against Phomopsis perniciosa and Botrytis cinerea, two non-pathogenic fungus. For spore germination, the corresponding ED50s are 45 and 410 μM[1].
References [1]. Kokubun T, et al. 2′,6′-Dihydroxy-4′-methoxyacetophenone, a phytoalexin from the roots of Sanguisorba minor. Phytochemistry, 1994, 35(2):331-333.
Additional Infomation 2',6'-dihydroxy-4'-methoxyacetophenone is a member of the class of acetophenones that is 2',4',6'-trihydroxyacetophenone in which the hydroxy group at position 4' is replaced by a methoxy group. It has a role as a plant metabolite and a phytoalexin. It is a monomethoxybenzene, a member of resorcinols and a dihydroxyacetophenone. It is functionally related to a 2',4',6'-trihydroxyacetophenone.
2',6'-Dihydroxy-4'-methoxyacetophenone has been reported in Kalmia latifolia and Sanguisorba minor with data available.

Solubility Data


Solubility (In Vivo) Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution 50 μL Tween 80 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO 400 μLPEG300 50 μL Tween 80 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO 100 μLPEG300 200 μL castor oil 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol 100 μL Cremophor 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH 400 μLPEG300 50 μL Tween 80 450 μL Saline)

Oral Formulations Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders

Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)